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The rapidly increasing prevalence of diabetes mellitus worldwide is one of the most serious and challenging health problems in 
the 21st century. Mammalian sirtuin 1 (SIRT1) has been shown to decrease high-glucose-induced endothelial cell senescence 
in vitro and prevent hyperglycemia-induced vascular dysfunction. However, a role for SIRT1 in prevention of hyperglyce-
mia-induced vascular cell senescence in vivo remains unclear. We used endothelium-specific SIRT1 transgenic (SIRT1-Tg) 
mice and wild-type (WT) mice to construct a 40-week streptozotocin (STZ)-induced diabetic mouse model. In this mode, 
42.9% of wild-type (WT) mice and 38.5% of SIRT1-Tg mice were successfully established as diabetic. Forty weeks of hyper-
glycemia induced significant vascular cell senescence in aortas of mice, as indicated by upregulation of expression of senes-
cence-associated markers including p53, p21 and plasminogen activator inhibitor-1 (PAI-1). However, SIRT1-Tg diabetic 
mice displayed dramatically decreased expression of p53, p21 and PAI-1 compared with diabetic WT mice. Moreover, man-
ganese superoxide dismutase expression (MnSOD) was significantly downregulated in the aortas of diabetic WT mice, but was 
preserved in diabetic SIRT1-Tg mice. Furthermore, expression of the oxidative stress adaptor p66Shc was significantly de-
creased in aortas of SIRT1-Tg diabetic mice compared with WT diabetic mice. Overall, these findings suggest that 
SIRT1-mediated inhibition of hyperglycemia-induced vascular cell senescence is mediated at least partly through the reduction 
of oxidative stress. 
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Diabetes mellitus is a major public health problem world-
wide, with estimated 285 million people affected. The prev-
alence of diabetes is also rapidly increasing, and is projected 
to rise to 366 million in 2030 [1]. Cardiovascular complica-
tions are the main cause of premature morbidity and mortal-
ity in diabetic patients [2]. As the first barrier of blood ves-
sels, the endothelium plays an extremely important role in 
maintaining vessel homeostasis [3]. Hyperglycemia is con-
sidered a key factor in the development of endothelial dys-
function, which is an early feature and the main cause of 
diabetic vascular complications [4,5].  
Aging is an independent risk factor for cardiovascular 
diseases. Senescent vascular cells have been detected in 
human atherosclerotic tissues and exhibit various functional 
abnormalities [6,7], suggesting that senescence of vascular 
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cells contributes to the pathophysiology of age-related  
vascular diseases. There is also in vivo evidence for the oc-
currence of vascular cell senescence in diabetic vasculopa-
thy [8,9]. Furthermore, high glucose-induced endothelial 
senescence exaggerates vascular inflammation and throm-
bosis in the vessels, promoting the development of diabet-
ic-associated cardiovascular events [10].  
Mammalian sirtuin 1 (SIRT1), the closest homolog of 
yeast sir2, functions as a NAD+-dependent histone deacety-
lase. SIRT1 is known to regulate cell proliferation, apopto-
sis, DNA damage repair, senescence and metabolism [11], 
and can control longevity in response to caloric restriction 
(CR) in many organisms, including yeast, worms, flies and 
possibly mammals [12]. We previously demonstrated that 
overexpression of endothelium-specific SIRT1 protects 
against endothelial dysfunction induced by a high-fat diet 
and hyperglycemia [13,14]. However, it remains unknown 
whether SIRT1 overexpression can inhibit hyperglyce-
mia-induced vascular cell senescence in vivo.  
Thus, in the present study, we constructed a 40-week 
streptozotocin (STZ)-induced diabetic mouse model and 
found that endothelium-specific overexpression of SIRT1 
significantly decreased expression of the senescence-   
associated markers p53, p21 and PAI-1 in the aortas of mice. 
Furthermore, the SIRT1-mediated inhibition of hypergly-
cemia-induced vascular cell senescence was mediated, at 
least in part, via a reduction in oxidative stress. 
1  Materials and methods 
1.1  Animals  
Mice were maintained in a temperature-controlled (25°C) 
facility with a 12 h light/12 h dark cycle and were given free 
access to food and water. Endothelial cell-specific trans-
genic mouse lines were established by microinjecting 
VE-SIRT1 plasmid into fertilized C57BL/6 eggs [13]. 
Briefly, full-length human SIRT1 cDNA was ligated with 
the mouse VE-cadherin promoter. The newly cloned 
PBSmVE-SIRT1 plasmid contains an SV40 polyA down-
stream of the SIRT1 cDNA. To generate and identify trans-
genic mice, the PBSmVE-SIRT1 plasmid was digested with 
SalI/BspHI, and the fragment was purified using agarose gel 
electrophoresis and a DNA recovery kit (QIAGEN, 
Duesseldorf, Germany). Donor eggs from C57BL/6 mice 
(provided by the Experimental Animal Center of the 
CAMS/PUMC) were prepared for microinjection. The in-
jected eggs were then transferred into the oviducts of pseu-
dopregnant KunMing mice as foster mothers (anesthetized 
by tribromoethanol saturated solution, 450 µL per mouse) 
and allowed to develop to term. Positive transgenic mice 
were identified by PCR and further confirmed by Southern 
blot analysis. Six-week-old male endothelium-specific 
SIRT1-Tg mice and WT littermates, weighing 1822 g, 
were used. All animal experiments were performed in ac-
cordance with the Guide for the Care and Use of Laboratory 
Animals published by the US National Institutes of Health 
(NIH Publication No. 85-23, revised 1996). 
1.2  Construction of the 8-week and 40-week strepto-
zotocin (STZ)-induced diabetic mouse model  
The 8-week STZ-induced diabetic mouse model was de-
veloped as previously described [14]. The 40-week 
STZ-induced diabetic mouse model was constructed as fol-
lows. Endothelium-specific SIRT1-Tg mice and WT litter-
mates were randomly divided into two groups. One group 
was made diabetic by peritoneal injection of STZ. STZ (50 
mg kg1 body weight; Sigma-Aldrich, Saint Louis, Missouri, 
USA) was freshly dissolved in sterile citrate buffer (0.05 
mol L1 sodium citrate, pH 4.5) and injected into mice 
within 10 min of preparation. Non-diabetic controls were 
treated with peritoneal injection of citrate buffer alone. STZ 
or citrate buffer was administered for five consecutive days 
during the first week of the study. Blood glucose was mon-
itored weekly using a one-touch blood glucose meter 
(Lifescan, Inc., Milpitas, CA, USA). Mice with a random 
blood glucose level >14 mmol L1 for 40 consecutive weeks 
after STZ injection were included in the diabetic group. 
Mice were anesthetized by intraperitoneal injection of 
Avertin (400 mg kg1) and sacrificed at 40 weeks after in-
jection. Hearts were perfused with cold 1× phosphate buff-
ered saline (PBS). The entire aorta from the heart to the iliac 
bifurcation was excised and placed in cold 1× PBS. The 
aorta was then cleaned of fat and loose connective tissue, 
frozen in liquid nitrogen, and stored at 80°C.  
1.3  Detection of biochemical indices 
Plasma samples were obtained from 6 h fasted mice after 40 
weeks of STZ injection. Total cholesterol, triglyceride, low 
density lipoprotein (LDL) and high density lipoprotein 
(HDL) levels were measured as previously described [13]. 
Glycated hemoglobin (HbA1c) contents of blood samples 
were measured with commercially available kits (Sig-
ma-Aldrich). 
1.4  Western blot analysis 
Aortas were isolated and snap-frozen in liquid nitrogen.  
The frozen aortas were successively pulverized and dis-
solved in Radioimmunoprecipitation Assay (RIPA) buffer 
(25 mmol L1 Tris-HCl pH 7.6, 150 mmol L1 NaCl, 1% 
NP-40, 1% sodium deoxycholate, and 0.1% SDS). After 
complete homogenization on an ice rotator, samples were 
sonicated and centrifuged at 4°C. The supernatants were 
transferred into fresh tubes and protein concentrations were 
determined by the Bicinchoninic Acid (BCA) assay. Equal 
amounts of protein (20 µg/lane) were separated by 
SDS-PAGE and transferred onto polyvinylidene difluoride  
membranes (Millipore, Billerica, Massachusetts, USA). 
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After being blocked, the filters were incubated with the fol-
lowing primary antibodies: anti-SIRT1 (07-131; Upstate, 
Billerica, Massachusetts, USA), anti-Shc (sc-1695; Santa 
Cruz Biotechnology, Santa Cruz, California, USA), anti-p53 
(sc-126; Santa Cruz Biotechnology), anti-MnSOD (M99920- 
050; BD Transduction Laboratories, San Jose, California, 
USA) and anti--actin (A5376; Sigma). After being washed 
and incubated with the appropriate horseradish peroxidase-    
conjugated secondary antibody (Santa Cruz Biotechnology), 
the immune complexes were visualized with a chemilumi-
nescence reagent. Western blots were quantified densito-
metrically with Quantity One software (Bio-Rad, Hercules, 
California, USA), and the intensity values were normalized 
to GAPDH.  
1.5  Statistical analysis 
Data are expressed as meanSEM. Statistical analyses were 
performed using the two-tailed unpaired Student t-test or by 
one-way analysis of variance (ANOVA) as appropriate, to 
determine statistical significance between the groups. A 
P-value less than 0.05 was considered significant. 
2  Results 
2.1  p53 and p21 expression is unchanged in aortas of 
8-week STZ-induced diabetic mice 
To examine the role of SIRT1 in hyperglycemia-induced 
vascular cell senescence, we constructed an 8-week 
STZ-induced type I diabetic mouse model with WT mice 
and endothelium-specific SIRT1-Tg mice, as previously 
described [14]. p53 and p21 were expressed at similar levels 
in lysed aortas from control-WT, control-Tg, diabetic-WT 
and diabetic-Tg mice (Figure 1). 
2.2  Characterization of 40-week STZ-induced WT and 
SIRT1-Tg diabetic mice 
To further elucidate the role of SIRT1 in hyperglycemia-  
 
Figure 1  p53 and p21 expression levels were unchanged in lysed aortas 
of 8-week STZ-induced diabetic mice. Protein expression was analyzed by 
Western blotting. A, Bar graphs show densitometric analysis of immunob-
lots of p53 protein. Data are presented as the mean±SEM of p53/GAPDH 
expression ratio (n=5 per group). Immunoblots for p53 and GAPDH are 
representative of five independent experiments. B, Bar graphs show densi-
tometric analysis of immunoblots of p21 protein. Data are presented as the 
mean±SEM of p21/GAPDH expression ratio (n=5 per group). Immunob-
lots for p21 and GAPDH are representative of five independent experi- 
ments. 
induced vascular cell senescence, we constructed a 40-week 
STZ-induced diabetic mouse model. We found that 42.9% 
of WT mice and 38.5% of SIRT1-Tg mice were successful-
ly established as diabetic at 40 weeks after STZ injection 
(Figure 2A). Analysis of blood biochemical indices demon-
strated no significant changes in total cholesterol, triglycer-
ides, HDL and LDL levels in SIRT1-Tg and WT diabetic 
mice compared with citrate buffer control mice (Table 1). 
Furthermore, there was no effect of SIRT1 overexpression 
on blood glucose levels at any time point (Figure 2B). 
2.3  Decreased expression of senescence-associated 
markers in aortas of 40-week STZ-induced diabetic mice 
with endothelial SIRT1 overexpression 
p53, p21 and PAI-1 are well established markers of senes 
cence [1519]. We found that expression of p53, p21 and 
PAI-1 was dramatically increased in aortas of 40-week 
STZ-induced diabetic mice compared with controls (Figure 3).   
Table 1  Biochemical data from SIRT1-Tg mice and WT littermates 40 weeks after induction of diabetes using STZ (citrate buffer injection as control)a) 










BW (g) 30.73±2.04 31.68±2.58 28.4±2.99* 28.8±3.95* 
TC (mmol L1) 1.92±0.12 2.00±0.11 1.98±0.21 2.13±0.38 
TG (mmol L1) 0.34±0.02 0.31±0.03 0.38±0.14 0.37±0.11 
HDL (mmol L1) 1.89±0.04 2.01±0.12 1.88±0.22 1.86±0.21 
LDL (mmol L1) 0.12±0.02 0.13±0.07 0.14±0.02 0.14±0.04 
Glucose (mol L1) 8.02±0.63 7.48±0.56 31.04±1.39** 30.82±1.66** 
HbA1c (%) 4.23±0.000 4.15±0.001 9.92±0.006** 9.66±0.008** 
a) *, P<0.05; **, P<0.01 vs. corresponding controls. BW, Body weight; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, 
low-density lipoprotein; HbA1c, glycated hemoglobin. 
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Figure 2  42.9% of WT mice and 38.5% of SIRT1-Tg mice were successfully established as diabetic 40 weeks after STZ injection and SIRT1 overexpres-
sion had no effect on blood glucose levels at any time point. A, Diabetic mice rate in WT and SIRT1-Tg mice (n=16 for WT, n=13 for SIRT1-Tg). B, Ran- 
dom blood glucose levels for continuous 40 weeks after injection. 
 
Figure 3  Endothelium-specific overexpression of SIRT1 decreases the expression levels of senescence-associated markers. Protein expression was ana-
lyzed by Western blotting. A, Bar graphs show densitometric analysis of immunoblots of p53 protein. Data are presented as the mean±SEM of p53/GAPDH 
expression ratio (n=5 per group). Immunoblots for p53 and GAPDH are representatives of five independent experiments. *, P<0.05 vs. WT control; #, 
P<0.05 vs. WT diabetic. B, Bar graphs show densitometric analysis of immunoblots of p21 protein. Data are presented as the mean±SEM of p21/GAPDH 
expression ratio (n=5 per group). Immunoblots for p21 and GAPDH are representative of five independent experiments. *, P<0.05 vs. WT control; #, P<0.05 
vs. WT diabetic. C, Bar graphs show densitometric analysis of immunoblots of PAI-1 protein. Data are presented as the mean±SEM of PAI-1/GAPDH ex-
pression ratio (n=5 per group). Immunoblots for PAI-1 and GAPDH are representative of five independent experiments. *, P<0.05 vs. WT control; #, P<0.05  
vs. WT diabetic. 
By contrast, expression of p53, p21 and PAI-1 was signifi-
cantly decreased in aortas of SIRT1-Tg diabetic mice com-
pared with WT diabetic mice.  
2.4  Endothelial SIRT1 overexpression reduced oxida-
tive stress in aortas of 40-week STZ-induced diabetic 
mice 
The expression of reactive oxygen species (ROS) is used as 
a determinant of hyperglycemia-induced endothelial dys-
function, which may contribute to vascular aging [20]. 
P66Shc has been shown to participate in mitochondrial ROS 
formation and to control the oxidative stress response 
[21,22]. Manganese superoxide dismutase (MnSOD) is the 
primary mitochondrial ROS scavenging enzyme that con-
verts superoxide to hydrogen peroxide. As such, p66Shc 
and MnSOD expression levels were used to reflect oxida-
tive stress in the mouse aortas. Diabetic mice exhibited an 
increase in p66Shc expression, but a decrease in MnSOD 
expression, in the aortas compared with controls (Figure 4). 
By contrast, SIRT1-Tg diabetic mice exhibited a significant 
decrease in p66Shc expression, but an increase in MnSOD 
expression, in the aortas compared with WT diabetic mice 
(Figure 4).  
2.5  Akt phosphorylation is unchanged in aortas of 
40-week STZ-induced SIRT1-Tg diabetic mice 
Activation of Akt has been reported to both promote and 
inhibit endothelial senescence [2325]. We found that 
phosphorylation of Akt was decreased in aortas of diabetic 
WT mice compared with controls (Figure 5). However,  
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Figure 4  Endothelium-specific overexpression of SIRT1 decreases 
p66Shc expression and increases MnSOD expression. Protein expression 
was analyzed by Western blotting. A, Bar graphs show densitometric anal-
ysis of immunoblots of p66Shc protein. Data are presented as the 
mean±SEM of p66Shc/GAPDH expression ratio (n=5 per group). Im-
munoblots for p66Shc and GAPDH are representative of five independent 
experiments. *, P<0.05 vs. WT control; #, P<0.05 vs. WT diabetic. B, Bar 
graphs show densitometric analysis of immunoblots of MnSOD protein. 
Data are presented as the mean±SEM of MnSOD /GAPDH expression 
ratio (n=5 per group). Immunoblots for MnSOD and GAPDH are repre-
sentative of five independent experiments. *, P<0.05 vs. WT control; #,  
P<0.05 vs. WT diabetic. 
 
Figure 5  Endothelium-specific overexpression of SIRT1 had no effect on 
phosphorylation of Akt. Protein expression was analyzed by Western blot-
ting. Bar graphs show densitometric analysis of immunoblots of total Akt 
and Ser473 phosphorylated Akt (Ser473 p-Akt). Data are presented as the 
mean±SEM of Ser473 p-Akt/Akt expression ratio (n=5 per group). Im-
munoblots for Ser473 p-Akt and Akt are representative of five independent  
experiments. *, P<0.05 vs. WT control. 
there was no difference in Akt phosphorylation in aortas of 
SIRT1-Tg diabetic mice compared with WT diabetic mice. 
3  Discussion 
In the present study, we demonstrated that endotheli-
um-specific SIRT1 overexpression inhibited the hypergly-
cemia-induced upregulation of the senescence-associated 
markers p53, p21 and PAI-1. Furthermore, SIRT1-Tg dia-
betic mice exhibited decreased expression of p66Shc, but 
increased expression of MnSOD. Thus, these data suggest 
that the protective role of SIRT1 against hyperglyce-
mia-induced vascular cell senescence is mediated, at least in 
part, through the reduction of oxidative stress.  
Accumulating evidence suggests that hyperglycemia par-
ticipates in vascular cell senescence and vascular aging 
[26,27]. An increase of oxidative stress is associated with 
the majority of pathways implicated in diabetic vasculopa-
thy, including the polyol and protein kinase C pathways 
[28]. Thus, these pathways may promote p53-dependent 
vascular cell senescence by increasing ROS levels. In sup-
port, disruption of p53 inhibits high glucose-induced endo-
thelial senescence and dysfunction [27]. We previously re-
ported that SIRT expression in aortas was decreased by a 
high-fat diet and hyperglycemia [13,14], but increased in 
mice with a CR diet [14,29], implying that SIRT1 might 
play a protective role in vascular aging. We also reported 
that SIRT1 overexpression significantly decreased high- 
glucose-induced senescence in HUVECs in vitro [14]. 
However, the p53 and p21 expression levels were un-
changed in the aortas of the 8-week STZ-induced diabetic 
mouse model. These data suggest that changes in senescent 
cells may predominantly occur in the endothelium instead 
of the whole aortas of diabetic mice at this stage. As such, 
we constructed a new diabetic mouse model by extending 
the period of STZ treatment to 40 weeks. In this model, WT 
diabetic mice displayed a significant elevation of p53, p21 
and PAI-1 expression levels in the aorta, which were sig-
nificantly reduced in SIRT1-Tg diabetic mice. This striking 
induction of p53, p21 and PAI-1 expression in our 40-week 
diabetic mouse model may represent the development of 
hyperglycemia-induced vascular cell senescence, which is 
reversed by endothelial overexpression of SIRT1.  
Oxidative stress is a major stimulus for the induction of 
senescence. A substantial body of evidence indicates that in 
endothelial cells, ROS generated from either intracellular or 
extracellular sources can induce or accelerate the develop-
ment of senescence by acting at multiple subcellular levels 
[30]. Hyperglycemia plays a central role in diabetic vascular 
complications. Among the full spectrum of biochemical 
effects of high glucose, overproduction of ROS is a key 
determinant of hyperglycemia-induced endothelial dysfunc-
tion and contributes to vascular aging [20]. Hyperglyce-
mia-mediated oxidative stress elicits irreversible growth 
arrest in endothelial cells, termed ‘stress-induced premature 
senescence’. Endothelial cell senescence has recently been 
postulated as an important cause of type-2 diabe-
tes-associated vascular aging. p66Shc has been shown to 
play a crucial role in the regulation of the oxidative stress 
response, while p66Shc deficient mice show an approximate 
30% increase in life span [21]. We found that p66Shc ex-
pression was significantly decreased, while MnSOD was 
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dramatically increased, in aortas of both 8-week [14] and 
40-week STZ-induced SIRT1-Tg diabetic mice, suggesting 
that the protective role of SIRT1 against oxidative stress 
contributes, at least in part, to its role in anti-aging. The 
signaling pathway of insulin/insulin-like growth fac-
tor-1/phosphatidylinositol-3 kinase/Akt is known to regulate 
longevity as well as resistance to oxidative stress in the 
nematode Caenorhabditis elegans [3133]. Reduction-of- 
function mutations in components of this pathway have 
been shown to extend the lifespan in organisms ranging 
from yeast to mice [34,35]. However, activation of Akt has 
been reported to both promote and inhibit endothelial se-
nescence [2325]. Here we found that Akt phosphorylation 
was decreased in aortas of diabetic mice, similar to previous 
findings [24]. By contrast, there was no change in Akt 
phosphorylation in aortas of 40-week STZ-induced SIRT1- 
Tg diabetic mice compared with WT diabetic mice. Thus, 
these data suggest that SIRT1 may inhibit hyperglyce-
mia-induced vascular cell senescence through reducing ox-
idative stress independently of Akt activity. Nevertheless, 
we cannot rule out the possibility that other mechanisms are 
involved in the anti-aging effect of SIRT1 in the endothelial 
cells.  
In conclusion, our data provide evidence that SIRT1 sig-
nificantly inhibited hyperglycemia-induced upregulation of 
senescence-associated markers in vivo. Therefore, inhibition 
of vascular cell senescence by activation of SIRT1 may be a 
potential therapeutic strategy for diabetes mellitus.  
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